186 related articles for article (PubMed ID: 23824420)
1. Genistein in the metabolic syndrome: results of a randomized clinical trial.
Squadrito F; Marini H; Bitto A; Altavilla D; Polito F; Adamo EB; D'Anna R; Arcoraci V; Burnett BP; Minutoli L; Di Benedetto A; Di Vieste G; Cucinotta D; de Gregorio C; Russo S; Corrado F; Saitta A; Irace C; Corrao S; Licata G
J Clin Endocrinol Metab; 2013 Aug; 98(8):3366-74. PubMed ID: 23824420
[TBL] [Abstract][Full Text] [Related]
2. Genistein and endothelial function in postmenopausal women with metabolic syndrome.
Irace C; Marini H; Bitto A; Altavilla D; Polito F; Adamo EB; Arcoraci V; Minutoli L; Di Benedetto A; Di Vieste G; de Gregorio C; Gnasso A; Corrao S; Licata G; Squadrito F
Eur J Clin Invest; 2013 Oct; 43(10):1025-31. PubMed ID: 23899172
[TBL] [Abstract][Full Text] [Related]
3. Age, abdominal obesity, and baseline high-sensitivity C-reactive protein are associated with low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein B responses to ezetimibe/simvastatin and atorvastatin in patients with metabolic syndrome.
Robinson JG; Ballantyne CM; Hsueh WA; Rosen JB; Lin J; Shah AK; Tomassini JE; Lowe RS; Tershakovec AM
J Clin Lipidol; 2013; 7(4):292-303. PubMed ID: 23890516
[TBL] [Abstract][Full Text] [Related]
4. Effects of the phytoestrogen genistein on some predictors of cardiovascular risk in osteopenic, postmenopausal women: a two-year randomized, double-blind, placebo-controlled study.
Atteritano M; Marini H; Minutoli L; Polito F; Bitto A; Altavilla D; Mazzaferro S; D'Anna R; Cannata ML; Gaudio A; Frisina A; Frisina N; Corrado F; Cancellieri F; Lubrano C; Bonaiuto M; Adamo EB; Squadrito F
J Clin Endocrinol Metab; 2007 Aug; 92(8):3068-75. PubMed ID: 17682090
[TBL] [Abstract][Full Text] [Related]
5. Does genistein lower plasma lipids and homocysteine levels in postmenopausal women? A meta-analysis.
Li J; Liu Y; Wang T; Zhao L; Feng W
Climacteric; 2016 Oct; 19(5):440-7. PubMed ID: 27338295
[TBL] [Abstract][Full Text] [Related]
6. Comparison of indices of insulin resistance with metabolic syndrome classifications to predict the development of impaired fasting glucose in overweight and obese subjects: a 3-year prospective study.
Shand BI; Scott RS; Lewis JG; Elder PA; Frampton CM
Int J Obes (Lond); 2009 Nov; 33(11):1274-9. PubMed ID: 19721448
[TBL] [Abstract][Full Text] [Related]
7. Moderate replacement of carbohydrates by dietary fats affects features of metabolic syndrome: a randomized crossover clinical trial.
Rajaie S; Azadbakht L; Khazaei M; Sherbafchi M; Esmaillzadeh A
Nutrition; 2014 Jan; 30(1):61-8. PubMed ID: 24290600
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of genistein aglycone on some cardiovascular risk factors and homocysteine levels: A follow-up study.
Marini H; Bitto A; Altavilla D; Burnett BP; Polito F; Di Stefano V; Minutoli L; Atteritano M; Levy RM; Frisina N; Mazzaferro S; Frisina A; D'Anna R; Cancellieri F; Cannata ML; Corrado F; Lubrano C; Marini R; Adamo EB; Squadrito F
Nutr Metab Cardiovasc Dis; 2010 Jun; 20(5):332-40. PubMed ID: 19631515
[TBL] [Abstract][Full Text] [Related]
9. Waist circumference provides an indication of numerous cardiometabolic risk factors in adults with cerebral palsy.
Ryan JM; Crowley VE; Hensey O; McGahey A; Gormley J
Arch Phys Med Rehabil; 2014 Aug; 95(8):1540-6. PubMed ID: 24742941
[TBL] [Abstract][Full Text] [Related]
10. The effect of dietary phytosphingosine on cholesterol levels and insulin sensitivity in subjects with the metabolic syndrome.
Snel M; Sleddering MA; Pijl H; Nieuwenhuizen WF; Frölich M; Havekes LM; Romijn JA; Jazet IM
Eur J Clin Nutr; 2010 Apr; 64(4):419-23. PubMed ID: 20179727
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness of the addition of ezetimibe to ongoing statin therapy in modifying lipid profiles and attaining low-density lipoprotein cholesterol goals in older and elderly patients: subanalyses of data from a randomized, double-blind, placebo-controlled trial.
Pearson T; Denke M; McBride P; Battisti WP; Brady WE; Palmisano J
Am J Geriatr Pharmacother; 2005 Dec; 3(4):218-28. PubMed ID: 16503317
[TBL] [Abstract][Full Text] [Related]
12. Thyroid function is associated with components of the metabolic syndrome in euthyroid subjects.
Roos A; Bakker SJ; Links TP; Gans RO; Wolffenbuttel BH
J Clin Endocrinol Metab; 2007 Feb; 92(2):491-6. PubMed ID: 17090642
[TBL] [Abstract][Full Text] [Related]
13. A 52-week, randomized, open-label, parallel-group comparison of the tolerability and effects of pitavastatin and atorvastatin on high-density lipoprotein cholesterol levels and glucose metabolism in Japanese patients with elevated levels of low-density lipoprotein cholesterol and glucose intolerance.
Sasaki J; Ikeda Y; Kuribayashi T; Kajiwara K; Biro S; Yamamoto K; Ageta M; Kobori S; Saikawa T; Otonari T; Kono S
Clin Ther; 2008 Jun; 30(6):1089-101. PubMed ID: 18640465
[TBL] [Abstract][Full Text] [Related]
14. Greater impairment of postprandial triacylglycerol than glucose response in metabolic syndrome subjects with fasting hyperglycaemia.
Jackson KG; Walden CM; Murray P; Smith AM; Minihane AM; Lovegrove JA; Williams CM
Metabolism; 2013 Aug; 62(8):1065-9. PubMed ID: 23598085
[TBL] [Abstract][Full Text] [Related]
15. Genistein for glycolipid metabolism in postmenopausal women: a meta-analysis.
Yi XY; Wang ZH; Wang Y
Climacteric; 2021 Jun; 24(3):267-274. PubMed ID: 33410719
[TBL] [Abstract][Full Text] [Related]
16. Short-term administration of orlistat reduced daytime triglyceridemia in obese women with the metabolic syndrome.
Tzotzas T; Samara M; Constantinidis T; Tziomalos K; Krassas G
Angiology; 2007; 58(1):26-33. PubMed ID: 17351155
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety profile of fenofibrate-coated microgranules 130 mg, with and without food, in patients with hypertriglyceridemia and the metabolic syndrome: an 8-week, randomized, double-blind, placebo-controlled study.
Davidson MH; Bays H; Rhyne J; Stein E; Rotenberg K; Doyle R
Clin Ther; 2005 Jun; 27(6):715-27. PubMed ID: 16117978
[TBL] [Abstract][Full Text] [Related]
18. The association between pulse wave velocity and metabolic syndrome and adiponectin in patients with impaired fasting glucose: cardiovascular risks and adiponectin in IFG.
Nam JS; Park JS; Cho MH; Jee SH; Lee HS; Ahn CW; Lowe WL; Kim KR
Diabetes Res Clin Pract; 2009 May; 84(2):145-51. PubMed ID: 19261346
[TBL] [Abstract][Full Text] [Related]
19. Elevated fasting glucose levels within normal range are associated with an increased risk of metabolic syndrome in older women.
Hsiao FC; Hsieh CH; Wu CZ; Hsu CH; Lin JD; Lee TI; Pei D; Chen YL
Eur J Intern Med; 2013 Jul; 24(5):425-9. PubMed ID: 23647841
[TBL] [Abstract][Full Text] [Related]
20. L-folic acid supplementation in healthy postmenopausal women: effect on homocysteine and glycolipid metabolism.
Villa P; Perri C; Suriano R; Cucinelli F; Panunzi S; Ranieri M; Mele C; Lanzone A
J Clin Endocrinol Metab; 2005 Aug; 90(8):4622-9. PubMed ID: 15899950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
